BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Apoptosis
,
Obesity
,
Endothelial cell
,
DNA fingerprint
,
Clofibrate
,
rs4950928
,
SIRT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Histone-lysine N-methyltransferase 2A
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Colon
Placenta
Small intestine
Ovary
Adipose tissue subcutaneous
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Anthrax
Disorder related to transplantation
Poisoning by drug AND/OR medicinal substance
Ebola virus disease
Carditis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
stachydrine chloride
Ketanserin
puerarin
Leukotriene E4
Domperidone
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
GATA5
PCDH11X
GLUD1
H2-Eb2
HLA-DQA1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Monocytes CD14+ from the blood of active or inactive Adult Still's disease (ASD) patients
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
LMP1 TES2-mediated expression in HEK293 cells with and without IkBalpha super-repressor
OMIM - Cancer
OMIM - Wiedemann-Steiner syndrome
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Histone-lysine N-methyltransferase 2A
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of JNJ-75276617 in Participants With Acute Leukemia
A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult …
A Study of JNJ-75276617 in Combination With Acute Myeloid Leukemia (AML) Directed Therapies
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ